Daily Journal Staff Writer
Ariosa Diagnostics Inc. and Natera Inc. won a decision Friday to invalidate a prenatal
testing patent held by Sequenom Inc. after the U.S. Court of Appeals for the Federal
Circuit affirmed a summary judgment ruling from the Northern District of California.
At the core of the lengthy courtroom battle was San Diego-based Sequenom'...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In